Quanterix Corporation

NASDAQ:QTRX

Medical - Devices

Healthcare
$2.03 +15.80%

+$0.46 today

Market cap
$96.38M
Beta
1.12
P/E (TTM)
-1.5
EPS (TTM)
-$2.22
52W Low $2.40High $8.77

Volume 2.13M

Average 1.15M

Returns on capital

Quanterix Corporation management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-36.2%

avg -29.7%

ROIC

-29.8%

avg -108.7%

ROA

-25.6%

avg -42.4%

Analysis

ROA is currently the strongest return metric at -25.6% versus its period average of -42.4%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Everett V. Cunningham

President, Chief Executive Officer & DirectorUSD 1.23M60——

Jason Faessler

Chief Financial Officer & TreasurerUSD 787.23K———

William Donnelly

Executive ChairUSD 258.64K64——

David R. Walt

Co-Founder & Chairman of Scientific Advisory BoardUSD 50.94K731.87M3.98%

Michael Miller

Chief Technology & Products Officer—62——

Joshua Young

Head of Investor Relations————

Anthony Catalano

Chief Operating Officer————

Daniel S. Char

Chief Legal Officer & Corporate Secretary—65——

Naren Bhat

Chief Strategy Officer————

Erica Bell

Chief People Officer—53——

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jan 2, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

3

$296,049.10

Sells

0

$0.00

Net Transaction Value

+$296,049.10

Net buying

Most Active

DONNELLY WILLIAM P

2 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Aug 13, 26

DONNELLY WILLIAM P

Indirect

Buy$211.7K
Aug 12, 26

DONNELLY WILLIAM P

Indirect

Buy$74.7K
May 12, 26

Meadows Benjamin

Direct

Buy$9.7K

Summary

Insiders reported 3 buys worth $296,049.10 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $296,049.10. DONNELLY WILLIAM P was the most active insider with 2 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A+9.5%
+10.0% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Recent growth has been strongest in Revenue at +9.5% over three years. Forward estimates point to Revenue at +10.0% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Quanterix Corporation compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about QTRX's management, answered from reported figures.

Who manages QTRX?

Quanterix Corporation (QTRX) lists 10 active executives. The top listed executive is Michael Miller, Chief Technology & Products Officer.

Are QTRX insiders buying or selling?

Recent insider activity shows net buying of $351,503.42.